Dendritic Cell Cancer Vaccine Market Poised for Robust Growth as Personalized Immunotherapy Advances Dendritic Cell Cancer Vaccine Market was valued at approximately USD 2.89 billion in 2024 and is projected to grow significantly at a CAGR of about 9.7 % from 2025 to 2032, driven by the rising global incidence of cancer and expanding adoption of personalized immunotherapy...